## Abstract The clinical efficacy of clozapine, an atypical antipsychotic, in treating levodopa‐induced hallucinations was investigated in five patients with Parkinson's disease under open label conditions. Two patients could not tolerate clozapine, even in doses as low as 12.5–25 mg daily, because
Clozapine for the treatment of psychosis in Parkinson's disease: a review
✍ Scribed by P. Auzou; C. Özsancak; D. Hannequin; N. Moore; P. Augustin
- Book ID
- 114784781
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 725 KB
- Volume
- 94
- Category
- Article
- ISSN
- 0001-6314
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Psychosis secondary to dopaminergic therapy can limit the ability to manage motor symptoms of advanced Parkinson's disease (PD). We report the results of an open label 3‐month trial that evaluated the antipsychotic effects of clozapine in eight PD patients with drug‐induced psychosis. R
Cases of delayed or acute posttraumatic, therapy-resistant tremor have been previously described. [1][2][3][4] The onset is usually delayed (weeks to months/years), but they may also begin rapidly (within hours). Careful neuroradiologic examination may reveal small lesions, often in the deep brain a